A particular Data analysis firm predicts Norspan to be a top seller by 2018.
Norspan aka Buprenorphine(wonderful drug) is of course the transdermal patch.
I think the stigma attached to OxyCodone/OxyContin will still be a major sticking point when transitioning Dr's from current products (Norspan, Targin, Fentynl, panadeine forte, tramadol etc)
IMO Mundipharma have this in the bag for the next 10 years.
chart update, page-135
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |